Takeda Pharmaceutical Co. Ltd. Introduces New Measles-Rubella Vaccine Published: Jan 31, 2006 Tokyo, Jan 31, 2006 (JCN) - Takeda Pharmaceutical announced on January 30 that it has launched Takeda, its proprietary measles-rubella (MR) vaccine. Related links JCN Newswire This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news